Page last updated: 2024-10-28

hydroxychloroquine and Neutropenia

hydroxychloroquine has been researched along with Neutropenia in 2 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Neutropenia: A decrease in the number of NEUTROPHILS found in the blood.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Nawar, T1
Morjaria, S1
Kaltsas, A1
Patel, D1
Perez-Johnston, R1
Daniyan, AF1
Mailankody, S1
Parameswaran, R1
Mahévas, M1
Audia, S1
De Lastours, V1
Michel, M1
Bonotte, B1
Godeau, B1

Other Studies

2 other studies available for hydroxychloroquine and Neutropenia

ArticleYear
Granulocyte-colony stimulating factor in COVID-19: Is it stimulating more than just the bone marrow?
    American journal of hematology, 2020, Volume: 95, Issue:8

    Topics: Adult; Aged; Betacoronavirus; Bone Marrow; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment

2020
Neutropenia in Felty's syndrome successfully treated with hydroxychloroquine.
    Haematologica, 2007, Volume: 92, Issue:7

    Topics: Felty Syndrome; Humans; Hydroxychloroquine; Neutropenia

2007